Only 62.5% of participants had good adherence to their lipid-lowering therapies at the end of the observation period, but this result showed a positive trend compared with predisclosure.
← all excerpts
Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk Reduction.
1
—
—